USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
USANA Health Sciences, Inc.NYSE: USNA
Net Receivables · Q1 FY2026 · quarter ended Apr 2026
Net receivables remains negative
Q1 FY2026 net receivables was $9.66M, compared with $0 a year earlier.
Context
- Net receivables amounted to 1.3% of total assets at the end of Q1 FY2026, up 1.3 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 0 | -100.0% |
| FY2024 | 2024-12-28 | 8.22M | +14.2% |
| FY2023 | 2023-12-31 | 7.2M | -0.2% |
| FY2022 | 2022-12-31 | 7.21M | +0.7% |
| FY2021 | 2021-12-31 | 7.16M | — |
Net Receivables vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Net receivables amounts to 1.3% of total assets for USNA, versus a peer median of 10.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | R$382.38M BRL | -22.7% | -0.3% | 10.1% | |
| Apr 2026 | $174.36M USD | +17.8% | -0.0% | 6.1% | |
WESTWestrock Coffee Company, LLC | Mar 2026 | $83.17M USD | -0.3% | -2.5% | 7.5% |
| Mar 2026 | CN¥41.5M CNY | -69.2% | +10.7% | 0.6% | |
| Mar 2026 | $36.28M USD | +34.3% | +16.2% | 16.7% | |
| Mar 2026 | $23.03M USD | +38.0% | +13.4% | 19.1% | |
| Apr 2026 | $13.21M USD | +127.6% | +24.1% | 15.1% | |
| Apr 2026 | $9.66M USD | — | — | 1.3% | |
| Peer median (excluding USNA) | — | +17.8% | +10.7% | 10.1% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 239.83M | 288.42M | 330.42M | 181.77M | 158.38M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 7.16M | 7.21M | 7.2M | 8.22M | 0 |
| Inventory | 98.32M | 67.09M | 61.45M | 69.74M | 102.61M |
| Other Current Assets | 3.68M | 7.12M | 7.28M | 5.7M | 27.42M |
| Total Current Assets | 362.85M | 381.23M | 417.75M | 279.19M | 288.41M |
| Property, Plant & Equipment (Net) | 125.57M | 117.77M | 99.81M | 94.57M | 94.38M |
| Goodwill | 17.67M | 17.37M | 17.1M | 144.17M | 137.96M |
| Intangible Assets | 30.44M | 32.43M | 29.92M | 151.82M | 133.15M |
| Long-term Investments | 23.82M | 2.9M | 2.83M | 2.74M | 0 |
| Tax Assets | 4.84M | 9.8M | 13.28M | 19.64M | 27.21M |
| Other Non-current Assets | 12.55M | 35.05M | 52.07M | 56.07M | 61.81M |
| Total Non-current Assets | 214.89M | 215.32M | 215.01M | 469.01M | 454.51M |
| Total Assets | 577.74M | 596.55M | 632.76M | 748.19M | 742.92M |
| Account Payables | 13.51M | 11.05M | 10.07M | 11.98M | 17.26M |
| Short-term Debt | 7.08M | 6.89M | 786K | 23M | 14M |
| Tax Payables | 5.19M | 4.97M | 12.53M | 11.76M | 0 |
| Deferred Revenue | 19.64M | 20.88M | 13.91M | 12.05M | 0 |
| Other Current Liabilities | 83.01M | 82.71M | 73.75M | (4.75M) | 97.3M |
| Total Current Liabilities | 160.79M | 143.83M | 118.85M | 139.63M | 128.57M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 7.5M | 4.07M | 4.55M | 4.07M | 4.89M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 4.11M | 7.28M | 7.02M | 7.97M | 23.19M |
| Total Non-current Liabilities | 21.83M | 18.24M | 16.71M | 22.24M | 28.08M |
| Total Liabilities | 182.62M | 162.08M | 135.56M | 161.86M | 156.64M |
| Common Stock | 19K | 19K | 19K | 19K | 18K |
| Retained Earnings | 344.64M | 391.64M | 445.22M | 478.94M | 465.72M |
| Accumulated OCI | 458K | (12.79M) | (13.7M) | (22.67M) | (16.18M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 54.22M | 53.17M |
| Total Equity | 395.12M | 434.47M | 497.2M | 586.33M | 586.27M |
| Total Debt | 17.3M | 13.78M | 13.21M | 39.2M | 14M |
| Net Debt | (222.54M) | (274.64M) | (317.22M) | (142.56M) | (144.38M) |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.